These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18808317)

  • 1. Expert opinion on tilarginine in the treatment of shock.
    Howes LG; Brillante DG
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1573-80. PubMed ID: 18808317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
    ; Alexander JH; Reynolds HR; Stebbins AL; Dzavik V; Harrington RA; Van de Werf F; Hochman JS
    JAMA; 2007 Apr; 297(15):1657-66. PubMed ID: 17387132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines.
    Freeman BD; Zeni F; Banks SM; Eichacker PQ; Bacher JD; Garvey EP; Tuttle JV; Jurgensen CH; Natanson C; Danner RL
    Crit Care Med; 1998 May; 26(5):877-86. PubMed ID: 9590318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.
    Dzavík V; Cotter G; Reynolds HR; Alexander JH; Ramanathan K; Stebbins AL; Hathaway D; Farkouh ME; Ohman EM; Baran DA; Prondzinsky R; Panza JA; Cantor WJ; Vered Z; Buller CE; Kleiman NS; Webb JG; Holmes DR; Parrillo JE; Hazen SL; Gross SS; Harrington RA; Hochman JS;
    Eur Heart J; 2007 May; 28(9):1109-16. PubMed ID: 17459901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock.
    Broccard A; Hurni JM; Eckert P; Liaudet L; Schaller MD; Lazor R; Perret C; Feihl F
    Shock; 2000 Jul; 14(1):35-40. PubMed ID: 10909891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tragedy of TRIUMPH for nitric oxide synthesis inhibition in cardiogenic shock: where do we go from here?
    Bailey A; Pope TW; Moore SA; Campbell CL
    Am J Cardiovasc Drugs; 2007; 7(5):337-45. PubMed ID: 17953472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate metabolism and muscle high energy phosphates during endotoxic shock in rats.
    Levy B; Valtier M; de Chillou C; Bollaert PE; Cane D; Mallie JP
    Shock; 1999 Feb; 11(2):98-103. PubMed ID: 10030795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock.
    Cotter G; Kaluski E; Blatt A; Milovanov O; Moshkovitz Y; Zaidenstein R; Salah A; Alon D; Michovitz Y; Metzger M; Vered Z; Golik A
    Circulation; 2000 Mar; 101(12):1358-61. PubMed ID: 10736276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
    Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
    Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in gastric intramucosal hydrogen ion concentration following endotoxin challenge in the rat and the actions of nitric oxide synthase inhibitors.
    Lamarque D; Whittle BJ
    Clin Exp Pharmacol Physiol; 2001 Mar; 28(3):164-8. PubMed ID: 11207670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postsynaptic α1-Adrenergic Vasoconstriction Is Impaired in Young Patients With Vasovagal Syncope and Is Corrected by Nitric Oxide Synthase Inhibition.
    Stewart JM; Suggs M; Merchant S; Sutton R; Terilli C; Visintainer P; Medow MS
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27444639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide in the pathogenesis of sepsis.
    Symeonides S; Balk RA
    Infect Dis Clin North Am; 1999 Jun; 13(2):449-63, x. PubMed ID: 10340177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo quantification of endotoxin-induced nitric oxide production in pigs from Na15NO3-infusion.
    Santak B; Radermacher P; Iber T; Adler J; Wachter U; Vassilev D; Georgieff M; Vogt J
    Br J Pharmacol; 1997 Dec; 122(8):1605-10. PubMed ID: 9422804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
    Teerlink T
    JAMA; 2007 Sep; 298(9):971-2; author reply 972-3. PubMed ID: 17785640
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined treatment with a nonselective nitric oxide synthase inhibitor (l-NMMA) and indomethacin increases ductus constriction in extremely premature newborns.
    Keller RL; Tacy TA; Fields S; Ofenstein JP; Aranda JV; Clyman RI
    Pediatr Res; 2005 Dec; 58(6):1216-21. PubMed ID: 16306196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
    Thiemermann C; Ruetten H; Wu CC; Vane JR
    Br J Pharmacol; 1995 Dec; 116(7):2845-51. PubMed ID: 8680715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse.
    Rees DD; Monkhouse JE; Cambridge D; Moncada S
    Br J Pharmacol; 1998 Jun; 124(3):540-6. PubMed ID: 9647479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N-methyl-L-arginine on cardiac and regional blood flow in a dog endotoxin shock model.
    Doursout MF; Kilbourn RG; Hartley CJ; Chelly JE
    J Crit Care; 2000 Mar; 15(1):22-9. PubMed ID: 10757195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
    Kielstein JT; Sydow K; Thum T
    JAMA; 2007 Sep; 298(9):971; author reply 972-3. PubMed ID: 17785641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.